ESMO Breast Cancer Congress 2019 1000x250

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Thursday 2 May 2019

Innovation in HR+, HER2–Advanced Breast Cancer and the Emerging Role of Biomarkers

Innovation in HR+, HER2–Advanced BreastCancer and the Emerging Role of Biomarkers Thumb

Novartis Satellite Symposium
Thursday 12:00 - 13:00
Berlin Hall
View the satellite invitation

Scientific Exchange Symposium: Estrogen Receptor Positive (ER+) Advanced Breast Cancer – What are the Therapeutic Approaches of the Future?

Estrogen Receptor Positive (ER+) Advanced Breast Cancer – What are the Therapeutic Approaches of the Future? Thumb

Eisai Satellite Symposium
Thursday 12:00 - 13:00
Viena Hall
View the satellite invitation

New Views on HER2-Positive Breast Cancer Low HER2, HER3 and Resistance

New Views on HER2-Positive Breast Cancer Low HER2, HER3 and Resistance Thumb

Medscape Satellite Symposium
Thursday 18:30 - 19:30
Berlin Hall
View the satellite invitation

Hitting Breast Cancer where it Hurts

Hitting Breast Cancer where it Hurts Thumb

Astrazeneca Satellite Symposium
Thursday 18:30 - 19:30
Vienna Hall
View the satellite invitation

Friday 3 May 2019

Advances in Triple-Negative Breast Cancer Care: Exciting Prospects in Personalised Cancer Immunotherapy

Advances in Triple-Negative Breast Cancer Care: Exciting Prospects in Personalised Cancer Immunotherapy Thumb

Roche Satellite Symposium
Friday 13:00 - 14:00
Berlin Hall
View the satellite invitation

Targeting HER Driven Breast Cancer Emerging and Future Options

Targeting HER Driven Breast Cancer Emerging and Future Options Thumb

Daiichi-Sankyo Satellite Symposium
Friday 13:00 - 14:00
Vienna Hall
View the satellite invitation

Changing the Trajectory of HR+/HER2- mBC: From Evidence to Clinical Practice

Changing the Trajectory of HR+/HER2- mBC: From Evidence to Clinical Practice Thumb

Pfizer Satellite Symposium
Friday 13:00 - 14:00
Riga Hall
View the satellite invitation

Addressing Ongoing Clinical Challenges: How Do We Optimize Patient Outcomes with CDK4/6 Inhibition In HR+/HER2- Breast Cancer?

Addressing Ongoing Clinical Challenges: How Do We Optimize Patient Outcomes with CDK4/6 Inhibition In HR+/HER2- Breast Cancer? Thumb

TouchIME Satellite Symposium
Friday 18:30 - 19:30
Berlin Hall
View the satellite invitation

Her Problem is Our Mission

Her Problem is Our Mission Thumb

Mylan Satellite Symposium
Friday 18:30 - 19:30
Vienna Hall
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings